002773:SHE
Chengdu Kanghong Pharma Grp Co Ltd
CNÂ¥19.44
arrow_downward
-1.92%(-0.38) 1D
Oct 16, 3:04:09 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 002773...
Open
CNÂ¥20.34
High
CNÂ¥20.34
Low
CNÂ¥19.30
Mkt. cap
18.61B
Avg. vol.
7.30M
Volume
6.59M
Dividend
3.60%
Quarterly dividend
CNÂ¥0.17
Ex-dividend date
Jun 9, 2026
P/E ratio
18.00
52-wk high
CNÂ¥36.10
52-wk low
CNÂ¥18.62
EPS
CNÂ¥1.08
Shares outstanding
921.33M
No. of employees
4K
Open
CNÂ¥20.34
High
CNÂ¥20.34
Low
CNÂ¥19.30
Mkt. cap
18.61B
Avg. vol.
7.30M
Volume
6.59M
Dividend
3.60%
Quarterly dividend
CNÂ¥0.17
Ex-dividend date
Jun 9, 2026
P/E ratio
18.00
52-wk high
CNÂ¥36.10
52-wk low
CNÂ¥18.62
EPS
CNÂ¥1.08
Shares outstanding
921.33M
No. of employees
4K
News stories
From web sources and news partners
Investopedia
·
50 minutes ago
Nasdaq Poised to End Run of Weekly Gains
ChartMill
·
1 hour ago
S&P 500 Gap Downs on October 16: MRNA, TWLO and COHR Lead Declines
StoneX
·
49 minutes ago
S&P 500 Forecast: SPX set for a weekly decline led lower by tech as AI worries linger
FXEmpire
·
30 minutes ago
Nasdaq and S&P Index: AI Selling Deepens as Dow Holds Up on Rotation
Profile
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion.
As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
About Chengdu Kanghong Pharma Grp Co Ltd